Katherine A Minson, Deborah DeRyckere, Douglas K Graham
{"title":"FLT3在急性髓系白血病中的抑制现状——缺陷与前景。","authors":"Katherine A Minson, Deborah DeRyckere, Douglas K Graham","doi":"10.4172/2576-1471.1000166","DOIUrl":null,"url":null,"abstract":"Katherine A Minson1,2, Deborah DeRyckere1 and Douglas K Graham1* 1Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, USA 2Department of Pediatrics, Atlanta, GA, USA *Corresponding author: Douglas K Graham, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, USA, Tel: (404) 727-5002; Fax: (404) 727-4455; E-mail: Douglas.Graham@choa.org","PeriodicalId":15288,"journal":{"name":"Journal of Cell Signaling","volume":"2 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2576-1471.1000166","citationCount":"3","resultStr":"{\"title\":\"The Current State of FLT3 Inhibition in Acute Myeloid Leukemia - Pitfalls and Promises.\",\"authors\":\"Katherine A Minson, Deborah DeRyckere, Douglas K Graham\",\"doi\":\"10.4172/2576-1471.1000166\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Katherine A Minson1,2, Deborah DeRyckere1 and Douglas K Graham1* 1Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, USA 2Department of Pediatrics, Atlanta, GA, USA *Corresponding author: Douglas K Graham, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, USA, Tel: (404) 727-5002; Fax: (404) 727-4455; E-mail: Douglas.Graham@choa.org\",\"PeriodicalId\":15288,\"journal\":{\"name\":\"Journal of Cell Signaling\",\"volume\":\"2 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2576-1471.1000166\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cell Signaling\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2576-1471.1000166\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/10/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cell Signaling","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2576-1471.1000166","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/10/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
The Current State of FLT3 Inhibition in Acute Myeloid Leukemia - Pitfalls and Promises.
Katherine A Minson1,2, Deborah DeRyckere1 and Douglas K Graham1* 1Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, USA 2Department of Pediatrics, Atlanta, GA, USA *Corresponding author: Douglas K Graham, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, USA, Tel: (404) 727-5002; Fax: (404) 727-4455; E-mail: Douglas.Graham@choa.org
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
